Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

被引:453
作者
Kimura, H
Morita, M
Yabuta, Y
Kuzushima, K
Kato, K
Kojima, S
Matsuyama, T
Morishima, T
机构
[1] Nagoya Univ, Sch Med, Dept Pediat, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Aichi Canc Ctr, Res Inst, Lab Viral Oncol, Nagoya, Aichi 464, Japan
[3] Nagoya First Hosp, Japanese Red Cross, Childrens Med Ctr, Div Hematol Oncol, Nagoya, Aichi, Japan
关键词
D O I
10.1128/JCM.37.1.132-136.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To measure the virus load in patients with symptomatic Epstein-Barr virus (EBV) infections, we used a realtime PCR assay to quantify the amount of EBV DNA in blood. The real-time PCR assay could detect from 2 to over 10(7) copies of EBV DNA with a wide linear range. We estimated the virus load in peripheral blood mononuclear cells (PBMNC) from patients,vith symptomatic EBV infections. The mean EBV-DNA copy number in the PBMNC was 10(3.7) copies/mu g of DNA in patients with EBV-related lymphoproliferative disorders, 10(4.1) copies/mu g of DNA in patients with chronic active EBV infections, and 10(2.2) copies/mu g of DNA in patients,vith infectious mononucleosis. These numbers were significantly larger than those in either posttransplant patients or immunocompetent control patients without EBV-related diseases. In a patient with infectious mononucleosis, the virus load decreased as the symptoms resolved. The copy number of EBV DNA in PBMNC from symptomatic EBV infections was correlated with the EBV-positive cell number determined by the in situ hybridization assay (r = 0.842; P < 0.0001). These results indicate that the real-time PCR assay is useful for diagnosing symptomatic EBV infection and for monitoring the virus load.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 40 条
  • [1] DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME
    BAER, R
    BANKIER, AT
    BIGGIN, MD
    DEININGER, PL
    FARRELL, PJ
    GIBSON, TJ
    HATFULL, G
    HUDSON, GS
    SATCHWELL, SC
    SEGUIN, C
    TUFFNELL, PS
    BARRELL, BG
    [J]. NATURE, 1984, 310 (5974) : 207 - 211
  • [2] Bai X, 1997, CLIN CHEM, V43, P1843
  • [3] BEUTLER E, 1990, BIOTECHNIQUES, V9, P166
  • [4] DETECTION OF CELL-FREE EPSTEIN-BARR-VIRUS DNA IN SERUM DURING ACUTE INFECTIOUS-MONONUCLEOSIS
    GAN, YJ
    SULLIVAN, JL
    SIXBEY, JW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) : 436 - 439
  • [5] A novel method for real time quantitative RT PCR
    Gibson, UEM
    Heid, CA
    Williams, PM
    [J]. GENOME RESEARCH, 1996, 6 (10): : 995 - 1001
  • [6] GRATAMA JW, 1994, BONE MARROW TRANSPL, P429
  • [7] EPSTEIN-BARR VIRUS-INDUCED B-CELL LYMPHOMA AFTER RENAL-TRANSPLANTATION - ACYCLOVIR THERAPY AND TRANSITION FROM POLYCLONAL TO MONOCLONAL B-CELL PROLIFERATION
    HANTO, DW
    FRIZZERA, G
    GAJLPECZALSKA, KJ
    SAKAMOTO, K
    PURTILO, DT
    BALFOUR, HH
    SIMMONS, RL
    NAJARIAN, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (15) : 913 - 918
  • [8] Real time quantitative PCR
    Heid, CA
    Stevens, J
    Livak, KJ
    Williams, PM
    [J]. GENOME RESEARCH, 1996, 6 (10): : 986 - 994
  • [9] Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
    Heslop, HE
    Ng, CYC
    Li, CF
    Smith, CA
    Loftin, SK
    Krance, RA
    Brenner, MK
    Rooney, CM
    [J]. NATURE MEDICINE, 1996, 2 (05) : 551 - 555
  • [10] DETECTION OF EPSTEIN-BARR-VIRUS TRANSCRIPTS IN CHEMICALLY OR IMMUNOLOGICALLY-ACTIVATED CELLS AND IN A NULL CELL-LINE (HLN-STL-C) BY IN-SITU HYBRIDIZATION WITH ALKALINE PHOSPHATASE-LINKED OLIGONUCLEOTIDE PROBES
    HIRONAKA, T
    NAGASAKI, M
    MORIKAWA, S
    HIRAI, K
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (2-3) : 141 - 154